Scarica l'app Stockscreener
79.96
0.26%
-0.21
Pre-mercato:
80.22
0.26
+0.33%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DXCM Giù?
Forum
Previsione
Frazionamento azionario
Dexcom Inc Borsa (DXCM) Ultime notizie
Stock Analysis | Dexcom OutlookA Cautionary Technical Outlook Amid Divergent Analyst Expectations - AInvest
FriskaAi Integrates with Dexcom’s CGM Data for AI-Powered Diabetes Management - HIT Consultant
FriskaAi and Dexcom Enter CGM Data Integration Agreement - The Joplin Globe
Saudi Arabia Blood Glucose Device Market Trends and Company - GlobeNewswire
Saudi Arabia Blood Glucose Device Market Trends and Company Analysis Report 2025-2033 Featuring Abbott Laboratories, Medtronic, Dexcom, Braun, DarioHealth, Sanofi, Bionime, and Novo Nordisk - Yahoo Finance
5 Revealing Analyst Questions From DexCom’s Q2 Earnings Call - Yahoo Finance
DXCM Q2 CY2025 Deep Dive: Volume Growth, Leadership Changes, and New Product Launches Shape Outlook - ca.finance.yahoo.com
How much upside does DexCom Inc. haveFree Investment Webinars - thegnnews.com
Dexcom Shares Drop 1.28% on 0.33B in Volume Ranking 313th as Institutions Cut Holdings Despite Earnings Surge - AInvest
DexCom Inc. Recovery Likely Here’s What Data ShowsEntry Alert Based on Volume Spikes Detected - metal.it
Tandem, Insulet monitoring CMS payment proposal for diabetes tech - MedTech Dive
Dexcom and Apple Watch team up to 'empower Aussies living with diabetes' - iTWire
DEXCOM ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Insulet Peer Tandem Diabetes Underwhelming Earnings, Dull Outlook Drags Stock - Benzinga
Inside Dexcom’s strategy to stay ahead in the $13.6bn CGM market - Yahoo Finance
Dexcom Rises 1.25% on Strong Earnings Amid Leadership Shift $370M Trading Volume Ranks 315th - AInvest
What You Need to Know Ahead of DexCom’s Earnings Release - MSN
DexCom (DXCM) Extends Losses on Day 5 Amid Leadership Change - MSN
DexCom Extends Losses Amid Leadership Change Amid Q2 Revenue Growth - AInvest
Diabetes Management App Market Is Booming So Rapidly: Dexcom, Glooko, AgaMatrix - openPR.com
Dexcom, Inc. shares rise 1.22% premarket as equity markets rebound on Fed rate cut bets. - AInvest
Global Diabetes Management Software Market Outlook 2022 - openPR.com
Day 5 of Loss Streak for DexCom Stock with -15% Return (vs. -2% YTD) [8/4/2025] - Trefis
Dexcom recall triggered by reports of speaker malfunctions - BioWorld MedTech
DexCom, Inc. (DXCM) Stock Analysis: Impressive 28.76% Upside With Strong Buy Ratings - DirectorsTalk Interviews
What are analysts’ price targets for DexCom Inc. in the next 12 monthsCapitalize on stocks with high profit margins - Jammu Links News
How volatile is DexCom Inc. stock compared to the marketCapitalize on high-yield stock opportunities - Jammu Links News
Is it the right time to buy DexCom Inc. stockCapitalize on emerging market sectors - Jammu Links News
Is DexCom Inc. stock overvalued or undervaluedExceptional portfolio growth - Jammu Links News
What analysts say about DexCom Inc. stockTriple-digit returns - Jammu Links News
What institutional investors are buying DexCom Inc. stockOverwhelming financial success - Jammu Links News
Is It Time to Buy DexCom at a Discount Before Growth Fully Materializes? - AInvest
DexCom Inc. Stock Analysis and ForecastOverwhelming profit margins - Jammu Links News
How many analysts rate DexCom Inc. as a “Buy”Fastest-growing stock picks - Jammu Links News
How does DexCom Inc. generate profit in a changing economyMaximize your portfolio’s earning potential - Jammu Links News
DexCom raises 2025 revenue guidance to $4.625B as type 2 non-insulin access expands - MSN
Does DexCom Inc. stock perform well during market downturnsInvest smarter with real-time trading signals - Jammu Links News
DexCom Receives 'Buy' Rating from Canaccord Genuity; Analyst Raises Price Target to $106 - AInvest
What is the risk reward ratio of investing in DexCom Inc. stockInvest like a pro with expert recommendations - jammulinksnews.com
Investors Hope for Bounce in DexCom Inc. After SelloffValue Investing Picks With Stability Outlined - metal.it
Dexcom Reports Strong Q2 2025 Growth and Leadership Change - MSN
DexCom (DXCM) Receives 'Buy' Rating from Canaccord Genuity | DXC - GuruFocus
Commit To Purchase DexCom At $50, Earn 6.2% Using Options - Nasdaq
DexCom, Inc. (NASDAQ:DXCM) Q2 2025 Earnings Call Transcript - Insider Monkey
Raymond James Maintains Buy Rating for Dexcom with $102 Price Target - AInvest
DexCom (DXCM) Q2 Revenue Jumps 15% - The Globe and Mail
DexCom Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Dexcom raises sales expectations, discusses G8 plans - MedTech Dive
DexCom stock price target raised to $106 from $105 at UBS - Investing.com Australia
DexCom (DXCM) Sees Target Price Upgrade Post-Quarterly Results - GuruFocus
Dexcom: Raymond James Keeps Strong Buy, PT Raised to $102 from $99. - AInvest
DexCom (DXCM) Receives a Price Target Boost from Baird - GuruFocus
DexCom (DXCM) Price Target Increased by Piper Sandler - GuruFocus
DexCom Q2 Earnings Beat Expectations, Raises 2025 Revenue Outlook - AInvest
DexCom (DXCM) Price Target Raised by Oppenheimer to $102 | DXCM Stock News - GuruFocus
DexCom Stock Falls Despite Q2 Earnings Beat & 2025 Sales View Raise - Yahoo Finance
1.24%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):